Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia
Article in Journal of Chemotherapy (May 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Journal of Chemotherapy (May 2024)
Article in Hematology/Oncology Clinics of North America (August 2023)
Article in Applied Health Economics and Health Policy (August 2023)